2009
DOI: 10.1248/bpb.32.463
|View full text |Cite
|
Sign up to set email alerts
|

Increased Plasma Dipeptidyl Peptidase IV (DPP IV) Activity and Decreased DPP IV Activity of Visceral But Not Subcutaneous Adipose Tissue in Impaired Glucose Tolerance Rats Induced by High-Fat or High-Sucrose Diet

Abstract: Several studies have investigated whether dipeptidyl peptidase IV (DPP IV) activity is correlated to the severity of diabetes; however, it remains unclear. To investigate the roles of DPP IV activity in metabolic abnormalities, impaired glucose tolerance rats were produced using a high-fat (HF) or high-sucrose (HS) diet. HF dietfed rats obviously exhibited impaired glucose tolerance, with increases in subcutaneous and epididymal fat mass, insulin resistance and dyslipidaemia. In rats fed a HS diet rather than … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
17
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 29 publications
3
17
1
Order By: Relevance
“…Previously, we found that plasma DPP4 activity was significantly greater in impaired glucose tolerance rats fed a high-fat or high-sucrose diet than in normal rats [6]. Additionally, using Otsuka Long-Evans Tokushima fatty rats, which display a spontaneously hyperphagic and obese phenotype in combination with hyperglycemia and hyperinsulinemia, we showed that plasma DPP4 activity changes in accordance with the progression of hyperinsulinemic obesity and pancreatic islet atrophy [7].…”
mentioning
confidence: 66%
See 1 more Smart Citation
“…Previously, we found that plasma DPP4 activity was significantly greater in impaired glucose tolerance rats fed a high-fat or high-sucrose diet than in normal rats [6]. Additionally, using Otsuka Long-Evans Tokushima fatty rats, which display a spontaneously hyperphagic and obese phenotype in combination with hyperglycemia and hyperinsulinemia, we showed that plasma DPP4 activity changes in accordance with the progression of hyperinsulinemic obesity and pancreatic islet atrophy [7].…”
mentioning
confidence: 66%
“…Although several clinical studies have investigated whether DPP4 activity is correlated with the onset or severity of diabetes and/or obesity, they have produced mixed results; i.e., plasma DPP4 activity levels were of 7-amino-4-methylcoumarin (AMC) from the synthetic substrate H-glycyl-prolyl-AMC (Gly-Pro-AMC; Sigma, St. Louis, MO, U.S.A.), as described previously [6][7][8]. Briefly, 5 μL of plasma were mixed with 35 μL of assay buffer (25 mmol/L HEPES, 140 mmol/L NaCl, 80 mmol/L MgCl 2 , and 1 % BSA; pH 7.8).…”
mentioning
confidence: 99%
“…Changes in DPP4 activity and Dpp4 mRNA levels may provide partial insights into the differences in the observed active GLP1 concentrations. DPP4 is a serine protease that inactivates polypeptides such as GLP1 and is expressed on the surface of various types of cells, including the small intestine, kidney, liver, and in a soluble form in plasma (Kirino et al 2009). While DPP4 activity in the plasma of S/MET and PGXCS/MET rats did not differ, there was a significant reduction in DPP4 activity in the kidney of PGXCS/MET rats compared with S/MET.…”
Section: Discussionmentioning
confidence: 99%
“…Total cholesterol concentration was measured in the blood using an automated analyzer (Polymer Technology Systems, CardioChek, PA, USA). Plasma DPP4 activity was measured according to Kirino et al (2009). A clinical chemistry panel was analyzed in serum and included: blood urea nitrogen, glucose, electrolytes, creatinine, alkaline phosphatase, aspartate aminotransferase (ALT), alanine aminotransferase (AST), and bilirubin.…”
Section: Cholesterol Dpp4 Activity and Clinical Chemistrymentioning
confidence: 99%
“…in DPP-IV in the intestine and kidney associated with a high fat diet 5 , while Kirino et al found that a high fat diet increased plasma DPP-IV activity 6 . Lamers et al reported that DPP-IV release was strongly correlated with adipocyte size, potentially representing an important source of DPP-IV in obesity 7 .…”
Section: Yang Et Al Demonstrated Increasesmentioning
confidence: 99%